Average Co-Inventor Count = 12.95
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Pharma Aktiengesellschaft (11 from 378 patents)
2. Bayer Intellectual Property Gmbh (6 from 721 patents)
3. Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts (2 from 119 patents)
4. Bayer Aktiengesellschaft (1 from 12,157 patents)
5. Bayer Pharma Aktiengessellschaft (1 from 2 patents)
17 patents:
1. 11866495 - Anti-CEACAM6 antibodies and uses thereof
2. 11773164 - Anti-CEACAM6 antibodies and uses thereof
3. 11667675 - MASP inhibitory compounds and uses thereof
4. 10604532 - Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases
5. 10584167 - Anti-CEACAM6 antibodies and uses thereof
6. 10428044 - 3-amino-1,5,6,7-tetrahydro-4H-indol-4-ones
7. 10350206 - Benzyl substituted indazoles as BUB1 inhibitors
8. 10266548 - Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases
9. 9890147 - 2,3-benzodiazepines
10. 9884063 - Amido-substituted azole compounds
11. 9765058 - Substituted benzylpyrazoles
12. 9745285 - Heteroaryl substituted pyrazoles
13. 9682974 - Heteroaryl substituted pyrazoles
14. 9676766 - Triazolopyridines
15. 9643953 - Substituted benzylpyrazoles